Original Articles (2016-)

  1. Sakugawa C, Haruyama Y, Tanaka H,Fukushima T, Kawaguchi M, Kataoka H.Prognostic significance of hepatocyte growth factor activator inhibitor type 1(HAI-1)immunoreactivity in pancreatic ductal adenocarcinoma. BMCResearch Notes, 10:674 (2017)
  2. Nonboe AW, Krigslund O, Soendergaard C, Skovbjerg S, Friis S, Andersen MN, Ellis V, Kawaguchi M, Kataoka H, Bugge TH, Vogel LK.HAI-2 stabilizes, inhibits, and regulates SEA-cleavage-dependent secretory transport of matriptase. Traffic, 18 : 378-391 (2017)
  3. Kanemaru A, Yamamoto K, Kawaguchi M, Fukushima T, Lin CY, Johnson MD, Camerer E, Kataoka H.Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer]associated fibroblasts by paracrine activation of protease]activated receptor 2. Int. J. Cancer, 140(1):130-141 (2016)
  4. Kawaguchi M, Yamamoto K, Kanemaru A, Tanaka H, Umezawa K, Fukushima T, Kataoka H.Inhibition of nuclear factor-ƒΘB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model. Oncotarget, 7:68614-68622 (2016)
  5. Inagaki-Ohara K, Okamoto S, Takagi K, Saito K, Arita S, Tang L, Hori T, Kataoka H, Matsumoto S, Minokoshi Y.Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice. Nutrition & Metabolism, 13:7 (2016)